COMMUNIQUÉS West-GlobeNewswire

PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018

28/11/2017 - 14:00

DELRAY BEACH, Fla., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, today announced that it projects consolidated year-over-year revenue [...]

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

28/11/2017 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

Transactions in relation to share buyback program

28/11/2017 - 13:50

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Arch Therapeutics to Provide Corporate Update at the 10th Annual LD Micro Main Event In Los Angeles December 5-7, 2017

28/11/2017 - 13:50

FRAMINGHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

28/11/2017 - 13:30

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing today announced that on November 21, 2017, the U.S. Patent and Trademark [...]

Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study of Otlertuzumab in Peripheral T-Cell Lymphoma

28/11/2017 - 13:02

Anticipates 2 IND Filings in 2018 for Novel Bispecific Antibody Candidates SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel [...]

Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2017

28/11/2017 - 13:00

CARLSBAD, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial results for the three and nine months ended September 30, 2017. To our [...]

Deciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal Tumors

28/11/2017 - 13:00

WALTHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ) a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced [...]

G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer

28/11/2017 - 13:00

RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, today announced a clinical trial collaboration with AstraZeneca to evaluate [...]

Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine

28/11/2017 - 13:00

Incorporates new molecular entity for migraine and Axsome’s MoSEIC™ technology Potential for superior efficacy as compared to current treatments FDA Pre-IND meeting written guidance received Issued U.S. patent provides [...]

ALK to launch updated corporate strategy on 4 December

28/11/2017 - 12:50

Copenhagen, 2017-11-28 12:50 CET (GLOBE NEWSWIRE) -- On Monday, 4 December 2017, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) will present its updated corporate strategy. That day at 11.00 a.m. (CET), ALK will host a [...]

ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering

28/11/2017 - 12:50

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ ReWalk ” or the “ Company ”) today announced that National Securities Corporation (“ National ”), [...]

Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update

28/11/2017 - 12:40

HEALOS trial with AM-111 did not meet the primary efficacy endpoint, but showed statistically and clinically significant effect in profound acute hearing loss subpopulation Phase 3 results from Keyzilen ® TACTT3 trial [...]

Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness

28/11/2017 - 12:40

HEALOS trial did not meet primary efficacy endpoint in overall study population Clinically and statistically significant improvement in subpopulation of patients with profound acute hearing loss Conference call [...]

Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350

28/11/2017 - 11:00

OKLAHOMA CITY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance), a leading full-service contract development and manufacturer of mammalian and microbial biologics, today announced that it has been [...]

US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert

28/11/2017 - 09:05

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces its research arm, Cannevert Therapeutics Ltd. (“CTL”) [...]

Cannabis Wheaton Income Corp. Announces Proposed Shares for Debt Settlement

28/11/2017 - 06:01

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") has entered into settlement agreements (the " [...]

Prima BioMed Becomes Immutep

28/11/2017 - 01:12

SYDNEY, Australia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- We refer to shareholder approval granted at the Company’s Annual General Meeting held on 17 November 2017 to change the name of the Company from ‘Prima BioMed Ltd’ to [...]

REVA to Present at 29th Annual Piper Jaffray Healthcare Conference

28/11/2017 - 00:37

SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Executive Officer, Ms. Reggie Groves, is scheduled to present at the 29th Annual [...]